| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.015 | 0.8 |